成人支原体肺炎采用莫西沙星治疗的效果及对肺功能指标的影响  

Investigation on the effect of moxifloxacin on adult mycoplasma pneumonia and its influence on pulmonary function indicators

作　　者：都雪艳 杜文革[1] 包蒙 Du Xueyan;Du Wenge;Bao Meng(Suzhou Yongding Hospital Co.,Ltd.,Jiangsu Suzhou 215200)

机构地区：[1]苏州永鼎医院有限公司,江苏苏州215200

出　　处：《中国社区医师》2021年第22期51-52,共2页Chinese Community Doctors

摘　　要：目的:探究莫西沙星治疗成人支原体肺炎的效果及对肺功能指标水平的影响。方法:2019年8月-2020年9月收治成人支原体肺炎患者60例,随机分为两组,各30例。对照组采用阿奇霉素治疗;试验组采用莫西沙星治疗。比较两组治疗效果。结果:试验组治疗总有效率高于对照组,差异有统计学意义(P<0.05);试验组治疗后第1秒用力呼气容积(FEV1)、用力肺活量(FVC)、第1秒用力呼气容积与用力肺活量比值(FEV1/FVC)水平均高于对照组,差异有统计学意义(P<0.05)。结论:莫西沙星治疗成人支原体肺炎的效果显著,可以有效改善患者肺功能指标水平。Objective:To explore the effect of moxifloxacin in the treatment of adult mycoplasma pneumonia and its influence on pulmonary function index levels.Methods:From August 2019 to September 2020,60 cases of adult patients with mycoplasma pneumonia were enrolled,they were randomly divided into two groups with 30 cases in each group.The control group was treated with azithromycin.The experimental group was treated with moxifloxacin.The therapeutic effects between the two groups was compared.Results:The total effective rate of treatment in the experimental group was higher than that in the control group,the difference was statistically significant(P<0.05).The lung function indicators such as FEV1,FVC,and FEV1/FVC in the experimental group were higher than those in the control group,the differences were statistically significant(P<0.05).Conclusion:The effect of moxifloxacin in the treatment of adult mycoplasma pneumonia is remarkable,which can effectively improve the levels of pulmonary function index.

关 键 词：支原体肺炎 成人 莫西沙星 肺功能 

分 类 号：R563.1[医药卫生—呼吸系统]